OutPerformDaily

  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks

Lost Password?
A Once-in-a-Generation Investment Opportunity: Is D-Wave Quantum the Best Way to Play This Monstrous Trend?

A Once-in-a-Generation Investment Opportunity: Is D-Wave Quantum the Best Way to Play This Monstrous Trend?

SoftBank Vision Fund books $2.4 billion quarterly gain boosted by OpenAI bet

Got $200? 1 Artificial Intelligence (AI) Stock to Buy and Hold for the Long Term.

Got $200? 1 Artificial Intelligence (AI) Stock to Buy and Hold for the Long Term.

Cisco Systems, Inc. (CSCO) Unveils Silicon One G300 Chip to Target $600B AI Infrastructure Opportunity

Cisco shares slide after earnings fail to wow the Street. Here’s our plan for the stock

The “Magnificent Seven” Plan to Spend $680 Billion Largely on Artificial Intelligence Capex: Is Now the Time to Pile Into the Group?

The “Magnificent Seven” Plan to Spend $680 Billion Largely on Artificial Intelligence Capex: Is Now the Time to Pile Into the Group?

OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
Inside the Push to Restart Three Mile Island’s Aging Nuclear Reactor
Uncategorized

Inside the Push to Restart Three Mile Island’s Aging Nuclear Reactor

January 14, 2025

The lights are turning back on at Three Mile Island, the site of America’s worst nuclear meltdown, after it has lain dormant for five years. WSJ goes...

Prediction: This Hypergrowth AI Stock Will Finish 2025 With the Largest Market Cap in the World (Hint: It’s Not Nvidia)
Uncategorized

Prediction: This Hypergrowth AI Stock Will Finish 2025 With the Largest Market Cap in the World (Hint: It’s Not Nvidia)

January 13, 2025

2024 was the year Nvidia — at least briefly — became the world’s largest company by market capitalization. Enter Amazon (NASDAQ: AMZN)...

Elon Musk Urges Mark Zuckerberg To Release Facebook Files, Calls It ‘Good’ After Meta Adopts X’s Community Notes-Like Feature
Uncategorized

Elon Musk Urges Mark Zuckerberg To Release Facebook Files, Calls It ‘Good’ After Meta Adopts X’s Community Notes-Like Feature

January 13, 2025

Tesla Inc. CEO Elon Musk endorsed calls for Meta Platforms Inc. (NASDAQ:META) to release its content moderation communications with government officials...

3rdPartyFeeds

Retailers post early holiday results — and Wall Street isn’t impressed

January 13, 2025

Lululemon, Abercrombie & Fitch and American Eagle all hiked their holiday guidance, but Abercrombie's growth is slowing. Read more...

Do Meta policy cutbacks suggest ‘convenience over conviction’?
Uncategorized

Do Meta policy cutbacks suggest ‘convenience over conviction’?

January 13, 2025

Mark Zuckerberg recently sat down with podcaster Joe Rogan for an episode published on January 10 for a nearly three-hour conversation following Meta (META)...

3rdPartyFeeds

Alphyn Capital Management’s Updates on Alphabet (GOOG)

January 13, 2025

Alphyn Capital Management, an investment management firm, released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. The...

3rdPartyFeeds

Here’s How Amazon.com (AMZN) is Demonstrating Sustainable Cash Flow Growth

January 13, 2025

Alphyn Capital Management, an investment management firm, released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. The...

3rdPartyFeeds

Abercrombie shares plunge 16% as retailers post early holiday results

January 13, 2025

Lululemon, Abercrombie & Fitch and American Eagle all hiked their holiday guidance, but Abercrombie's growth is slowing. Read more...

Broadcom’s AI Boom: Citi Sets $220 Target as Revenue and Dividends Soar
Uncategorized

Broadcom’s AI Boom: Citi Sets $220 Target as Revenue and Dividends Soar

January 13, 2025

How Broadcom Is Thriving Despite U.S.-China Tensions and Skyrocketing AI Demand

Mediar Therapeutics signs licensing deal with Eli Lilly for IPF treatment
Uncategorized

Mediar Therapeutics signs licensing deal with Eli Lilly for IPF treatment

January 13, 2025

Mediar will receive a combined $99m consisting of an upfront payment and near-term milestones.

Previous 1 … 172 173 174 175 176 … 8,434 Next
Indices by TradingView
A Once-in-a-Generation Investment Opportunity: Is D-Wave Quantum the Best Way to Play This Monstrous Trend?

A Once-in-a-Generation Investment Opportunity: Is D-Wave Quantum the Best Way to Play This Monstrous Trend?

February 12, 2026

SoftBank Vision Fund books $2.4 billion quarterly gain boosted by OpenAI bet

February 12, 2026
Got $200? 1 Artificial Intelligence (AI) Stock to Buy and Hold for the Long Term.

Got $200? 1 Artificial Intelligence (AI) Stock to Buy and Hold for the Long Term.

February 11, 2026

Cisco Systems, Inc. (CSCO) Unveils Silicon One G300 Chip to Target $600B AI Infrastructure Opportunity

February 11, 2026

Cisco shares slide after earnings fail to wow the Street. Here’s our plan for the stock

February 11, 2026

Categories

  • 3rdPartyFeeds
  • Cannabis Stocks
  • Index Funds
  • International
  • News
  • Short
  • Stock Picks
  • Tech Stocks
  • Uncategorized
Indices by TradingView
While subscribers receive the benefit of Outperformdaily opinions, none of the information contained therein constitutes a recommendation from Outperformdaily that any particular security, portfolio of securities, transaction, option, or investment strategy is suitable for any specific person. You further understand that we will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. To the extent any of the information contained in Outperformdaily may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person. Outperformdaily’s past results are not necessarily indicative of future performance. All investments are subject to loss. Our employees and writters typically personally invest in all recommendations, but they are not obligated too. Our employees and writters are prohibited from taking an opposite position from which they write about.